ArticlePleura and peritoneum2026

Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress.

Vinita Popat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.